Lior Raviv | Vice President ,Development & Operations
Pluristem Therapeutics
Lior Raviv joined Pluristem in 2011 and currently serves as Vice President of Development in charge on process & technology development and manufacturing sciences. Prior to that Mr. Raviv served as Projects manager & Product development Team leader at Pluristem in charge of new technologies and process development. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries. Mr. Raviv holds a M.Med.Sec in pharmacology from the Ben Gurion University and a B.S.c, in Biotechnology engineering from the Ben Gurion University.
Appearances:
Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 13:30
Panel: Patient Delivery in the COVID environment
Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 14:10
What’s worked well in patient delivery?
Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 16:30
Workshop: New commercial products: moving from clinical to commercial
·Interacting with pharma companies (i.e. how to administer X)·Moving from bags to vialsoPreparing the dose on-site, how to calculate the correct dosage all the way to patient delivery·POC/commercialisation·Moving from proprietary -> streamlining·Allogeneic:oDosage/amountoDispensing as a pharmacyoVerification process
last published: 10/May/21 08:45 GMT
Organiser
